Clinical trials

  • (S)-N-(5-(4-(1-(BENZO[D][1,3]DIOXOL-5-YL)ETHYL)PIPERAZIN-1-YL)-1,3,4-THIADIAZOL-2-YL)ACETAMIDE, HYDROCHLORIDE SALT for Progressive supranuclear palsy
  • TEMOZOLOMIDE for Medulloblastoma | High-risk medulloblastoma
  • LY3938577 for Type 1 diabetes mellitus
  • ATROPINE SULFATE MONOHYDRATE for Myopia
  • CARVEDILOL for Idiopathic ventricular arrhythmias | Ventricular extrasystoles | Monomorphic ventricular tachycardia
  • VENETOCLAX for Acute myeloid leukemia (NPM1-mutated)
  • FOSFOMYCIN TROMETAMOL for Male urinary tract infection
  • ZONGERTINIB for HER2-mutated or HER2-overexpressing/amplified solid tumours
  • Humanised IgG1 kappa fragment antibody targeting TFR1 conjugated to P125 oligonucleotide for Myotonic dystrophy type 1
  • CLOXACILLIN SODIUM for Staphylococcus aureus infection
  • ADAGRASIB for Non-small cell lung cancer|KRAS G12C mutation
  • CRISPR-TIL for Advanced or metastatic melanoma | Malignant melanoma (stage III/IV)